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A TRANSCRANIAL DOPPLER STUDY COMPARING CEREBROVASCULAR 
REACTIVITY IN PATIENTS WITH ACUTE STROKE AND TRANSIENT 
ISCHEMIC ATTACK. 
Norman Whitmire, Jr., Frank Pavalkis, Pierre B. Fayad, Erfan A. Albakri, and 
Lawrence M. Brass. Department of Neurology, Yale University School of 
Medicine, New Haven, CT. 
The autoregulatory capacity of the brain is important to the maintenance of 
adequate perfusion in the face of changes in blood pressure or blood oxygen 
concentration. Disruptions of the cerebral vasculature, such as that seen in 
stroke and transient ischemic attack (TIA) can create disruption of that 
autoregulatory capacity. An understanding of the mechanisms and 
characteristics of cerebral autoregulation may help guide the management of 
acute stroke patients and may help in the prevention of stroke in patients with 
transient ischemic attack. 
Twenty-six patients were studied using transcranial Doppler ultrasound. 
Each was given 1 gram of intravenous acetazolamide (Diamox) and monitored 
for 30 minutes in order to quantify the cerebrovascular reactivity, which could be 
inferred from the increase in blood velocity on TCD. 
The stroke patients had significantly lower reactivity on the affected side 
than did the TIA patients on the same side (p = 0.02). Non-lacunar strokes 
demonstrated significantly lower reactivity than did lacunar strokes (p = 0.02). 
Patients with superficial (cortical) lesions showed significantly lower reactivity 
than did those with deep (subcortical) lesions (p = 0.05). The stroke patients, 
those with non-lacunar strokes, and those with superficial lesions demonstrated 
■ 
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significantly lower reactivities (p < 0.01 for all three groups), compared to normal 
subjects. 
Reactivity testing in cerebrovascular disease may be useful in guiding acute 
management and in screening for stroke. 

1 
1. Introduction & Literature Review 
1.1 Introduction 
The brain is absolutely vital to the independent survival of all human beings. Its 
proper functioning depends on an adequate supply of oxygen and glucose. 
Despite being only 2% of body weight, the brain receives 15% of the total blood 
supply (Vander et al., 1985). There are very tight controls on the cerebrovascular 
system in order to insure that adequate oxygen will be able to meet the metabolic 
needs of the brain at any given time, for a wide range of blood pressures. The 
controls are mediated through vascular innervation that also responds to a 
number of endogenous vasodilating and vasoconstricting substances. 
Disruption of the cerebral vasculature causes dysfunction of this control 
mechanism. Atherosclerosis, microvascular changes, like those seen in diabetes, 
or vascular defects, such as arteriovenous malformations can affect these vessels' 
ability to respond to the appropriate endogenous stimuli. In addition, occlusive 
processes, such as a thrombus or an embolus can create a state where vessels are 
maximally stimulated and are unable to respond appropriately to blood pressure 
changes. 
Altered cerebral hemodynamics is an important factor in the pathophysiology 
of ischemic diseases of the brain (e.g., transient ischemic attack and stroke). It 
affects the cerebrovascular response to blood pressure changes and, thus, the 
capability of adequate brain perfusion. Techniques, such as those that measure 
cerebrovascular reactivity, can test the reserve capacity of brain vasculature and 
provide an idea of how well these blood vessels can autoregulate cerebral blood 
flow, especially in the setting of ischemic brain disease. These techniques 
involve the exogenous administration of physiologic substances, like carbon 
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dioxide, or drugs (e.g., acetazolamide) which increase the serum concentration of 
carbon dioxide. Changes in autoregulatory capacity are easily identified. 
Careful monitoring of reactivity may be useful in guiding the therapy and 
management of some stroke patients. Patients in whom reactivity—therefore, 
autoregulation—is impaired may require more careful blood pressure control to 
insure maximal brain perfusion. However, as the vasomotor reserve capacity 
improves, such tight controls can become more liberal, as the brain vasculature 
will be better able to deal with blood pressure changes. 
This thesis is a description of research using transcranial Doppler ultrasound 
that focuses on changes in cerebrovascular reactivity of patients immediately 
following a stroke or transient ischemic attack. Comparisons were made 
between patients with stroke and TIAs, and between the locations of the brain 
lesions. In Chapter 1 of this thesis, some of the previous literature concerning 
autoregulation, transcranial Doppler ultrasound, and cerebrovascular reactivity 
will be reviewed; this will set the context for the study here. Chapter 2 will 
describe the methods used to conduct this research. The results will be presented 
in Chapter 3; a number of tables and graphs have been provided to facilitate 
understanding of the findings. Finally, Chapter 4 will be a forum for discussion 
of those results and will provide suggestions for future investigations. 
1.2 Autoregulation 
Autoregulation is the physiological regulatory mechanism that maintains a 
constant flow over wide ranges of arterial blood or perfusion pressure. In the 
brain, this can be defined as "the occurrence of vasodilatation in response to a 
decrease in cerebral perfusion pressure and the occurrence of vasoconstriction in 
response to increased cerebral perfusion pressure" (Paulson et al., 1990). 
Autoregulation is dependent on cerebrovascular tone, and demonstrates an 
. 
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inverse relationship between the rate of regulation and PaC02 (Aaslid et al., 
1989). 
Mechanisms of Autoregulation 
Paulson et al., 1990 cite four mechanisms of cerebrovascular autoregulation 
described in the literature: myogenic, metabolic, perivascular nerves, and 
endothelial cell-related factors. The first mechanism is the myogenic which 
suggests that smooth muscle of the cerebral blood vessels responds to changes in 
transmural pressure. The small arteries then constrict or dilate in responses to 
increases or decreases in the pressure, respectively. This is facilitated by a change 
in the state of actin and myosin filaments in smooth muscle cells. 
The second mechanism, the metabolic mechanism suggests that CC>2, H+, O2, 
adenosine, adenine, K+ and Ca2+ may serve as mediators in the coupling of 
neuronal activity and blood flow. The exact mechanism of this is not known, 
however. In addition, the renin-angiotensin system may play a key role in this 
by controlling vasoconstriction (Paulson and Waldemar, 1991). 
The third mechanism cited is regulation by perivascular nerves. Nerve fibers 
which originate from cranial ganglia provide autonomic motor and sensory 
input to cerebral blood vessels. At rest the autonomic system has little influence 
on cerebral blood flow; autoregulation is maintained by the smaller resistance 
vessels. However, when activated by endogenous (e.g. ischemia) or exogenous 
(e.g. CO2 and acetazolamide) factors, the upper limits of autoregulation may be 
shifted to higher pressures. Conversely, acute denervation may shift the limits 
of autoregulation toward lower pressures; chronic stimulation may not have any 
effect. 
The fourth mechanism cited by Paulson et al. (1990) involves factors released 
from endothelial cells. They point out that endothelium-derived relaxing factor 
■ 
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(EDRF) may be released from a blood vessel in response to higher blood flow 
within that vessel, causing a vasodilation. 
The process of autoregulation is a complex one. Many systems are involved 
in its proper functioning. Understanding of how it works can guide therapy and 
management in situations where autoregulation is compromised or lost. 
1.3 Cerebrovascular Reactivity 
1.3.1 General 
Carbon dioxide (CO2) is the normal physiological modulator of cerebral blood 
flow (CBF) and plays a key role in an exquisite control mechanism. Increases in 
arterial blood C02 tension cause marked vasodilation. In addition, it changes 
arteriolar resistance by altering the pH in perivascular and intracellular vascular 
smooth muscle. This is possible because C02 can diffuse into the smooth muscle 
from brain tissue and from the vessels; hydrogen ions, on the other hand, are 
prevented from reaching vascular smooth muscle because of the blood-brain 
barrier. This results in an inverse relationship between cerebral blood vessel 
diameter and pH. (Berne and Levy, 1986) 
It can be administered exogenously in order to induce vascular changes 
associated with hyper- and hypocapnia. The ratio of percent change in CBF 
plotted against the change in pC02 is defined as reactivity (DeWitt et al., 1993). 
The figure below is an example of a C02-reactivity plot (adapted from Ringelstein 
and Otis, 1992): 
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Figure 1-1. Normal vasomotor reactivity using CO2. The x-axis represents the 
volume of gas used; the y-axis represents the percent change in velocity from 
baseline (100%). 
Changes in CBF can be measured by a variety of means, including single¬ 
photon emission computed tomography (SFECT), positron-emission 
tomography (PET), and transcranial Doppler ultrasound (TCD) (Rogg et al., 1989). 
In the normal patient, hypercapnia should cause an increase in CBF detectable by 
PET or SPECT, and a velocity increase by TCD. A marked decrease in MCA 
response to hypercapnia (e.g. in the setting of carotid artery occlusion), suggests a 
compensatory vasodilation of vessels distal to the ICA (Bishop et al., 1986), as a 
consequence of these resistance vessels being maximally dilated (Ringelstein and 
Otis, 1992). 
1.3.2 Acetazolamide in Vasomotor Reactivity 
Although CO2 is one of the physiologic substances that induces cerebral 
vasodilation, acetazolamide (Diamox) produces a similar effect. Acetazolamide 
is an inhibitor of carbonic-anhydrase, the enzyme which facilitates the 
conversion of CO2 to HC03~ in the proximal tubule of the kidney and in 
erythrocytes (Sorteberg et al., 1989; Warnock, 1989). Inhibition of this enzyme 
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results in an increase in the blood concentration of CO2 and mimics the effects of 
direct CO2 administration. 
The use of acetazolamide has been shown to be as accurate a method of 
inducing vasodilation as CO2 in testing cerebrovascular reactivity (Piepgras et al., 
1990; Ringelstein et al., 1992; Sorteberg et al., 1989). It creates a physiologic state 
that correlates to the direct inhalation of CO2; however, at least 1 gram of the 
drug must be used to equal the same response (Hague et al., 1983; Ringelstein et 
al., 1992; Vorstrup et al., 1984). The advantages of using acetazolamide are that it 
is easy to administer, is independent of patients cooperation, and less 
uncomfortable to the patient. The disadvantage is that it induces only a 
vasodilatory response, so the vasoconstrictive capacity of vessels cannot be 
evaluated (Ringelstein et al., 1992). 
1.4 Transcranial Doppler Ultrasound 
1.4.1 General Principles (Aaslid, 1992; Brass et al., 1989; Caplan et al., 1990; 
Tegeler and Eicke, 1993) 
The Doppler Principle 
Christian A. Doppler (1803-1853), an Austrian physicist, described a wave 
principle concerning the relationship between the velocity of moving objects and 
the resulting frequencies of the reflected signal. This is given by the formula: 
V 
f = f2 - f0 = 2 • f0 • c 
(f = Doppler shift; f2 = resultant frequency; f0 = incident frequency; V = velocity of object; c = speed of sound) 
Basics of Diagnostic Ultrasound 
Diagnostic ultrasound takes advantage of this principle by emitting a sound 
wave from a transducer at 1 to 20 MHz. A moving erythrocyte shifts the 
■ 
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frequency in proportion to the velocity. If blood is moving toward the 
transducer, the wave is shortened; conversely, if the blood cell is moving away 
from the transducer, the wave is lengthened. The measured velocity is a 
component of the velocity along the line of insonation and is proportional to the 
cosine of the angle of insonation (<j>) by the transducer. Blood flow moving 
directly toward the transducer is measured at 1.00 times the real velocity; blood 
traveling toward the transducer where <]> = 60° will be measured at 0.5 times the 
velocity; and blood moving at an angle of 90° to the transducer will measure a 
velocity of zero. Thus, the resultant formula for flow velocity, corrected for <J) is: 
c f 
V =-•7- 
2 • cos(|) *0 
Transcranial Doppler Ultrasound (TCP) 
Early Doppler ultrasound devices utilized continuous sound waves pulsed at 
2 to 10 MHz. This technique encountered limitations when attempting to 
penetrate the skull, because of impaired impedance coupling1 due to the density 
of bone. Aaslid et al., 1982 discovered the technique of using shorter frequency 
(1-2 MHz) pulsed waves which penetrate the skull better. That led to the 
development of transcranial Doppler (TCD) ultrasound. 
Intracranial arteries can be sonated through a number of "windows" located 
at the temporal, occipital, and frontal bones. These correlate with the three 
approaches used in transcranial investigation: the transtemporal (temporal 
squama), transorbital (orbit), and the suboccipital/transnuchal (foramen 
1 Impedance coupling is the phenomenon that occurs when sound waves traveling through one 
medium encounter a different medium. For example, sound traveling through the ocean will be 
heard underwater, but not in the air above; similarly, the reverse is true with regard to sound 
traveling through air. 
' 
:■ 
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magnum). The arteries that can be insonated through each approach are given 
below (adapted from von Reutern and von Biidingen, 1993): 
transtemporal- middle cerebral 
terminal segment of the internal carotid 
anterior cerebral (A1 segment) 
anterior communicating 




internal carotid siphon 
anterior cerebral 
suboccipital- vertebral (intracranial portions) 
posterior inferior cerebellar 
basilar 
Identification of Blood Vessels 
Individual intracranial blood vessels can be located using four parameters: 
adjustment of the angle of insonation, depth of insonation, comparison of the 
shape of the wave-form, and the direction of blood flow2. 
Normal Parameters in Identifying the MCA 
The middle cerebral artery (MCA) can be easily identified via the 
transtemporal window. The transducer should be placed immediately superior 
to the zygomatic arch and directed perpendicular to the bone. The MCA is found 
at a depth between 35-60 mm with direction of flow moving toward the 
transducer. Mean velocities range from 41 to 70 cm/sec and decreases inversely 
with age; however, low hematocrit levels may result in velocity increases. 
2Above the baseline = toward the transducer; below the baseline = away from the transducer 
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Resistance should be low with PI of approximately 0.90 ± 25. (Brass et al., 1988; 
DeWitt et al., 1993) 
1.4.2 Clinical Uses of TCD 
Transcranial Doppler ultrasound is a useful technique in evaluating conditions 
affecting the cerebrovascular system, and it is commonly used in a wide variety 
of settings. The major uses of TCD include the following (adapted from AAN, 
1990): 
• detection of severe stenosis (>65%) in the major basal intracranial 
arteries 
• assessment of the patterns and extent of collateral circulation in 
patients with known regions of severe stenosis or occlusion 
• evaluation and following of patients with vasoconstriction of any 
cause, especially after subarachnoid hemorrhage (SAH) 
• detection of arteriovenous malformations (AVMs) and the study 
of their supplying arteries and flow patterns 
• assessment of patients with suspected brain death 
Other Possible Uses of TCD 
Table 1-1 below lists a number of other situations/disorders where TCD may 
be useful: 
Disease Reference 
AVM Lindegaard et al., 1986 
brain death Bode et al., 1988 
Dernbach, 1989 
Newell et al., 1989 
brain function Harders et al., 1989 
dementia Foerstl et al., 1989 
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migraine Giller et al., 1990 
Thie et al., 1990 
Thie et al., 1990 
normal pressure 
hydrocephalus 
Fritz et al., 1989 
pediatrics Bode and Harders, 1989 
Bode and Eden, 1989 
Chadduck et al., 1991 
post-partem Bogousslavsky et al., 1989 
Shy-Drager syndrome Briebach et al., 1989 
sickle cell disease Adams et al., 1988 
Brass et al., 1991 
surgery Awad and Little, 1991 
Bass et al., 1989 
Benichou et al., 1991 
Bernstein, 1990 
Brass, 1990 
Padayachee et al., 1987 
Table 1-1. Other possible situations using TCD. These uses have not been 
officially established. 
1.4.3 Use of TCD in Reactivity Testing 
Use in Ischemic Disease 
Measurement of cerebrovascular reactivity with TCD is useful in ischemic 
disease. As discussed above, resistance arterioles supplying the brain undergo 
dilation in response to the hypercapnia associated with ischemia. Reactivity is a 
measurement of the vasodilatory response of these vessels in the presence of an 
exogenous stimulus, such as CO2 or acetazolamide. This decreased response has 
been demonstrated in a number of studies (Kleiser et al., 1991; Ringelstein et al., 
1988; Widder et al., 1994). Transcranial Doppler provides a means of evaluating 
reactivity that is non-invasive, portable, and time-saving. The two pages which 
follow show examples of a normal (Figure 1-2) and an abnormal (Figure 1-3) 
TCD-reactivity tracing. 
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Other Uses of Reactivity Studies 
Reactivity in number of other settings has also been studied. These include 
subarachnoid hemorrhage (Dernbach et ah, 1988; Hassler and Chioffi, 1989; 
Romner et al., 1991), migraine (Harer and von, 1991; Thie et al., 1992; Zwetsloot 
et al., 1991), various types of surgery (Hartl et al., 1994; Karnik et al., 1992; Lundar 
et al., 1985; Russell et al., 1990), head injury (Tenjin et al., 1990), and brain 
hemorrhage (Klingelhofer and Sander, 1992). The specific findings of these 
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Patient Identification and Acquisition 
Patients for this study were identified by consulting the admission log for the 
Neurology service at Yale-New Haven Hospital. Those patients who met the 
following criteria were placed under further consideration: 
• Probable stroke or transient ischemic attack by clinical history and 
diagnostic imaging work-up 
• No other concurrent medical conditions that might confound the results of 
the study (e.g. Severe hypertension) 
• Conditions that might be exacerbated by the use of acetazolamide (e.g. 
electrolyte imbalance or severe acidosis) 
Exclusions were based on the following criteria: 
• Equivocal clinical presentation 
• Poor signals through the transtemporal bone window on either side 
• The reactivity study could not be performed within seven days of the 
stroke or TIA 
Patients who met the initial inclusion criteria underwent a routine 
transcranial Doppler ultrasound study. If they demonstrated acceptable 
transtemporal bone windows that allowed an adequate Doppler signal, they were 
then informed of the acetazolamide-reactivity test which would be performed as 
an adjunct procedure to the routine TCD study. The procedure was thoroughly 
explained to them, making sure they understood the purpose of the test, what to 
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expect during and following the tests, and the risks of the test. A procedure note 
and statement of verbal consent were included in the patient's chart. 
Patient Demographics 
A total of 61 patients (48 strokes, 13 TIAs) met the initial inclusion criteria. Of 
those, 32 subjects (52%) were excluded for a variety of reasons. Most of the 
exclusions were based on inadequate Doppler signals secondary to poor 
transtemporal bone windows. In addition, there was one patient with an 
equivocal diagnosis, and one patient whose symptoms were of psychogenic 
origin. The remaining exclusions consisted of patients who refused to participate 
in the study altogether. Finally one patient who underwent a complete 
acetazolamide-reactivity study had to be excluded after it was discovered that the 
wrong blood vessel had been insonated. 
We studied 26 patients (15 men, 11 women). The mean patient age for stroke 
patients participating in the study was 61 years (s.d. = ±18); among TIA patients, 
the mean age was 56 years (±16). These patients were divided by diagnosis (based 
on the discharge diagnosis recorded in the medical record) and by lesion site 
(based on official CT and/or MRI reports). The distribution of patient diagnoses 
is given in table 2.1 below: 
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Diagnosis Tvpe # of Patients Percent 
Stroke non-lacunar 14 78% 
lacunar 4 22% 
Total 18 100% 
Lesion Site superficial 9 50% 
deep 8 44% 
combined 1 6% 
Total 18 100% 
TIA Total 8 100% 
Total Patients Studied 26 
Table 2-1. Demographic information of the patients included in this study. 
Transcranial Doppler Equipment 
Three different transcranial Doppler (TCD) ultrasound units were used 
during the course of this study as the manufacturer developed updated models 
and software versions. The first device used was a Transpect TCD (Medasonics, 
Mountain View, CA). 12 patients were tested this unit. 
The second unit was an updated model, the Medasonics Cerebrovascular 
Diagnostic System (CDS), version 1.1. Improvements were made in signal 
clarity, as well as hardware capabilities. 7 patients were tested using this updated 
device. The software for this version was updated to version 1.3.6, which further 
enhanced the capabilities and clarity of the machine and output. 4 patients were 
tested using the newer software. 
The last TCD device used was the Medasonics CDS, version 2.1 Bilateral 
Doppler System. This updated unit permitted simultaneous bilateral testing. 6 
patients were tested using the latter device. 
■ 
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Transducers 
Ultrasound signals were generated using a 2 MHz pulsed Doppler transducer. 
The pulse repetition frequency is adjustable to 3.9, 5.25, 7.8, or 10.5 kHz by 
software under user control. The spatial peak temporal average intensity of the 
ultrasound is 161 mW/cm2. Since the first two models permitted only unilateral 
testing, two transducers were attached to a switcher box that was manually 
alternated between left and right during every minute of testing time. 
Attachment of the Transducers 
The transducers used with the first TCD unit were specially-designed so that 
they could be attached to a helmet that fit around the patient's head. After an 
adequate signal was obtained, the transducers were secured with a small screw 
located on either side of the helmet. The test then proceeded. Transducer 
placement had to be carefully monitored to avoid loss of signal if the patient 
suddenly moved. 
The other two TCD units did not utilize a helmet. Instead, the transducers 
were fixed directly onto the patient either by an elastic band or with surgical 
cement. The elastic band was preferred, because of the extreme difficulty 
associated with application and removal of the cement. 
Printer 
Beginning with the use of the TCD unit CDS, version 1.3.6, studies were 
printed using a Hewlett-Packard Printrex 412 thermal printer. Recordings during 
the test were first stored on the hard disk and later retrieved and printed for 
filing. 
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Testing Procedure 
The best transtemporal window on each side was located and the middle 
cerebral arteries identified first by a hand-held probe; the location was noted 
either by placing a pen mark or by the impression left by the conducting gel. The 
securable probes were then connected to the machine. For the Transpect and 
earliest CDS Doppler units, the two probes were connected to the switcher box 
then the box was connected to the machine. On the CDS Bilateral Doppler 
System the probes could be connected directly to the machine via two ports 
located in the back. Once the MCAs were re-identified, the probes could be 
attached as described in the section above. 
Prior to the test, baseline velocities were recorded for three to five minutes; 
these were averaged to result in one baseline velocity for each side. Although a 
single recording may have been sufficient, the average of many recordings was 
chosen to reduce the possibility of an aberrant baseline velocity influencing the 
outcome of the test. When the baseline value was recorded, the patient was 
given 1 gram of acetazolamide (Diamox) intravenously via the cubital vein or 
dorsal vein of the hand, followed by a lOcc saline flush.3 When an intravenous 
line or "hep-lock" line was not present, the infusion was done through a 
"butterfly" line. 
The beginning of infusion was counted as "time zero" (TO). In order to avoid 
one data point greatly skewing the outcome, one reading was taken every fifteen 
seconds and averaged to obtain the peak (systolic) velocity for that minute. Then 
the unit would be switched to measure and readings for the following minute 
would be taken in the same manner. This method of alternate minute readings 
3Although the preparation, set-up, and testing were all performed by NW (the principal 
investigator), the acetazolamide was administered by a licensed physician or certified physician's 
associate. 
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continued throughout the duration of the examination. The TCD unit, version 
2.1 possessed improved insonation capabilities and accuracy, as well as the ability 
for taking simultaneous bilateral Doppler recordings. Therefore, use of the 
alternating method was no longer necessary, and only one reading per minute 
was required. 
Timing of the Procedure 
The time involved for the entire procedure was as follows: baseline = 3-5 
minutes; post-acetazolamide = 25-30 minutes. The duration of baseline 
recordings was chosen in order to reduce the possibility of a skewed value from 
an aberrant data point. The duration of the test following the infusion of 
acetazolamide is based on previous studies which demonstrated a rise in systolic 
velocity during the first five minutes after giving acetazolamide followed by a 
plateauing of the velocity lasting approximately thirty minutes (Hague et al., 
1983; Ringelstein et al., 1992). Some examinations were terminated early (i.e., 
after 20-25 minutes), however, if the patient became extremely tired or agitated. 
One patient became agitated after fifteen minutes, so the study was terminated; 
this did not affect the outcome, since the plateau phase had been reached. The 
patient suffered no other ill effects. 
Recording the Studies 
The Medasonics Transpect TCD and the CDS, version 1.1 units were linked to 
a Realistic, model 16-616 videocassette recorder and Panasonic WV-5410 
monitor. Each study was recorded in its entirety and reviewed after the study to 
obtain individual minute readings. Appropriate labeling was done during the 
test so that the correct blood vessel and time could easily be identified. The 
updated CDS, version 1.3.6 and the CDS, version 2.1 (bilateral TCD) did not have 
' 
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a video board; therefore, studies were recorded on the hard disk drive. These 
were retrieved in the office following the test, and the resulting images were 
printed out using the HP Printrex 412 thermal printer. 
Data Evaluation 
The raw values were entered into a Microsoft Excel spreadsheet for further 
calculations (a sample is provided in the Appendix section). The recorded peak 
(Vs) and mean (Vm) velocities, as well as the pulsatility index (PI) for each 
minute were entered; the spreadsheet was designed to calculate automatically the 
diastolic velocity using the formula for calculating the pulsatility index as 
defined by (Gosling and King, 1974) and solving for the diastolic velocity (Vd) as 
below: 
Vd = Vs-Vm.PI 
All baseline peak velocities (Vs) and pulsatility indices (PI) were averaged to 
obtain one baseline value. When four values per minute were recorded, those 
values were averaged as the Vs and PI for that minute; when only a single value 
was recorded, that was used for the minute Vs and PI. Those values were further 
averaged to result in average post-acetazolamide velocities during the period 
after 7-15 minutes, 10-20 minutes and 21-30 minutes. We observed that the 
velocity continued to rise between TO and seven minutes; in all patients, the 
increase in velocity had reached a plateau by seven minutes. 
The rise in peak velocity was accompanied by a concomitant decrease in the 
pulsatility index. This was caused by the dilation of the resistance arterioles 
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distal to the MCA and served as confirmation that the vasomotor response had 
occurred.4 
Cerebrovascular Reactivity: The Formula 
The highest average post-acetazolamide (post-ACZ) Vs was then compared to 
the baseline Vs to obtain the percent cerebrovascular reactivity (CVR), using the 
formula below (Ringelstein et al., 1992; Sorteberg et al., 1989): 
CVR = %AV = 
’(Post-ACZ Vs - baseline Vs) 
baseline Vs x 100 
A similar formula was used to obtain the percent change in the pulsatility index 
(PI). The ranges of the Vs were also recorded as were the % difference in Vs on 
the right as compared to the left. Finally a graph of each minute data point was 
generated by the computer. An example of this data sheet is provided in the 
Appendix section. 
Follow-Up Studies 
Follow-up acetazolamide-reactivity studies were performed on six of the 26 
patients. Three patients were re-tested one week after their initial examination 
(i.e., approximately 14 days after their ischemic event). Three patients were re¬ 
examined during a subsequent visit to the outpatient neurology clinic. The 
remainder of the patients did not have follow-up studies, because of refusal to 
participate in the follow-up study, failure to keep their outpatient clinic 
4The mean velocities and pulsatility indices were not recorded in the patients tested with the 
Transpect TCD unit (12 patients). It was decided following this series of patients that those two 
parameters might be useful in data confirmation and evaluation, so they are recorded in all 
subsequent studies. 
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appointment, or because of investigator conflicts with required medical school 
classes. 
Patient Information Database 
Each patient's chart was reviewed after discharge and selected information 
was entered into a Double Helix database created by the principal investigator of 
this project. (A blank example of the information sheet is provided in the 
Appendix section.) The information sheet lists basic identification information 
about the patient, such as the name, hospital number, age, date of birth, and the 
attending and resident physicians who took care of that patient. 
Next there is a section in which information pertaining to the study is 
recorded. This section includes the date of admission and discharge, the age of 
the patient at the time of the event as well as the estimated date of the event 
itself. These fields are used to calculate the number of days between the ischemic 
event and the reactivity study. There is also a set of fields for similar 
information if a follow-up study was performed. In addition, there is a field each 
for the admitting and discharge diagnoses; information entered here is taken 
from the printed discharge summary. At the end of the section there are two 
boxed areas in which the highest CVR for each side is recorded; there is a box for 
both the initial study and follow-up. 
A brief medical history section is included next. Information entered here 
comes directly from the admission history and physical written by the neurology 
resident. There are fields for the chief complaint; history of present illness; past 
medical history, citing specifically any history of past stroke or heart disease; past 
surgical history, in particular any neurological surgeries; history of smoking, 
alcohol, or drug abuse; family history, medications, allergies. A physical exam 
field is included for any physical findings pertinent to the current illness. 
■ 
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Finally, there is a section for course of treatment and progress, which includes 
the results from any diagnostic tests (e.g., duplex carotid ultrasound, MRI, CT, 
and angiogram). 
Classification of Strokes by Type 
Subjects were broadly classified by the diagnosis noted at the time of discharge 
(ischemic stroke or TIA)5. The stroke patients were subclassified into lacunar 
and non-lacunar strokes, based lesions found by CT or MRI; these classes were 
chosen in order to compare strokes of different pathogenesis and prognosis. The 
non-lacunar strokes were further divided into deep, superficial, and combined 
lesions, so that comparisons between strokes of different sizes could be made. 
Statistical Calculation Software 
Statistical information used in the reactivity test result sheet are created using 
Microsoft Excel 4.0. All other statistical information was generated using the 
InStat v.l software package. 
5 Two patients were classified based on the clinical presentation and outcome, instead of the 
discharge diagnosis recorded in the medical record. Thus, one patient whose discharge diagnosis 
was TIA, suffered a stroke (with residual deficits), and another patient whose diagnosis was stroke 
suffered a TIA (i.e. complete resolution of symptoms within 20 minutes of onset). A third patient 
who presented with TIAs and underwent reactivity testing suffered a completed stroke one week 




Comparison of the data was made between the stroke patients and those with a 
TIA. Values obtained from both groups were also compared with values in 
normal subjects obtained from a previous study (Sorteberg et al., 1989). 
Comparisons of the reactivity (CVR) between the symptomatic groups were 
made using an unpaired Mann-Whitney test, which does not assume gaussian 
distribution of the data. Comparisons to normal subjects were done using an 
unpaired Student's f-test. 
3.1 Comparison of Patients with Brain Ischemia 
Baseline Peak Velocities 
The following table shows the average baseline (pre-acetazolamide) velocities 
(± standard deviation) in all stroke patients and all TIA patients. 
Table 3-1. Mean Baseline Systolic Velocities (cm/s) 
Ipsilateral Contralateral 
All Strokes (n = 18) 95 (±40) 98 (±53) 
Superficial (n = 9) 105 (±52) 98 (±67) 
Deep (n = 8) 85 (±25) 101 (±43) 
Combined (n = 1) 91 (0) 96 (0) 
Lacunar (n = 4) 73 (±17) 76 (±18) 
Non-lacunar (n = 14) 102 (±43) 105 (±59) 
TIA (n = 8) 88 (±20) 89 (±25) 
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The baseline systolic velocities were significantly higher for both stroke and 
TIA patients (p < 0.01) than velocities expected in normal subjects (Vs = 65 cm/s ± 
6) (Sorteberg et alv 1989). 
Post-acetazolamide Peak Velocities 
The following table shows the average post-acetazolamide (post- 
acetazolamide) velocities (± standard deviation) in all stroke patients and all TIA 
patients. 
Table 3-2. Post-acetazolamide Peak Velocities (cm/s) 
Ipsilateral Contralateral 
All Strokes (n = 18) 117 (±44) 128 (±66) 
Superficial (n = 9) 124 (±55) 127 (±84) 
Deep (n = 8) 111 (±35) 133 (±49) 
Combined (n = 1) 99 (0) 98 (0) 
Lacunar (n = 4) 96 (±29) 100 (±31) 
Non-lacunar (n = 14) 122 (±47) 136 (±72) 
TIA (n = 8) 120 (±25) 123 (±34) 
The baseline systolic velocities were significantly higher for both stroke 
patients (p - 0.01) and TIA patients (p = 0.02) than velocities expected in normal 
subjects (Vs = 88 ± 6 cm/s) (Sorteberg et al., 1989). 
All Stroke Patients versus All TIA Patients 
Stroke patients (n = 18), regardless of the type or location of the lesion, 
demonstrated an ipsilateral CVR (±s.d) = 23.79% (±12.19) and a contralateral CVR 
= 30.56% (±12.22). TIA patients (n = 8) demonstrated an ipsilateral CVR = 37.05% 
' 
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(±10.43) and a contralateral CVR = 37.61% (±11.27). CVR on the affected 
(ipsilateral) side was significantly lower (p = 0.02) in stroke patients than in TIA 
patients. The unaffected (contralateral) side did not show a significant difference 










All Strokes TIA 
Type of Ischemic Event 
■ Ipsilateral aContralateral 
Graph 3-1. Comparison of CVR between all stroke patients and those with TIA 
for brain hemispheres ipsilateral and contralateral to the side of ischemic event. 
Lacunar Infarcts versus Non-lacunar Infarcts 
Patients with non-lacunar infarcts (n = 14) showed CVR (±s.d.) = 21.70% 
(±11.05) ipsilaterally and CVR = 30.59% (±12.18) contralaterally. Patients with 
lacunar infarcts (n = 3) showed CVR = 38.39% (±3.58) on the ipsilateral side and 
CVR = 37.46% (±3.52) contralaterally. Ipsilateral CVR in patients with non- 
' 
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lacunar infarcts was significantly lower (p = 0.02) than in patients with lacunar 














Classification of Stroke 
■ Ipsilateral n Contralateral 
Graph 3-2. Comparison of CVR in lacunar and non-lacunar strokes. 
Superficial Infarcts versus Deep Infarcts 
Patients demonstrating superficial (cortical) infarcts (n = 9) demonstrated a 
mean ipsilateral CVR (±s.d.) = 20.21% (±11.90) and contralateral CVR = 31.32% 
(±13.36). Patients with deep (subcortical) infarcts (n = 8) showed a mean 
ipsilateral CVR = 29.67% (±10.53) and mean contralateral CVR = 33.28% (±5.81). 
Patients with superficial lesions showed significantly lower CVR (p = 0.05) than 
patients with deep (sub-cortical) infarcts. Contralateral CVR was not significant 
(0.48). 
6 One lacunar infarct data point was excluded, because it was considered an outlying point. 
Inclusion of this data point made the comparison of lacunar and non-lacunar infarcts slightly not 
significant on the affected side. 
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Brain Level of Infarct 
nlpsilateral □ Contralateral 
Graph 3-3. Comparison of CVR in patients with superficial and deep lesions. 
Patients with Combined Deep and Superficial Lesions 
Given the small sample size (n = 1), proper statistical comparisons could not 
be performed. However, this patient demonstrated one of the lowest CVRs of all 
the groups: Ipsilateral CVR = 8.85% and contralateral CVR = 2.07%. 
3.2 Comparison of Reactivities in Affected Patients to Previously Studied 
Normal Subjects 
The following results are comparisons of the patients tested for this study with 
normal subjects tested in a previous study (Sorteberg et al., 1989). The 
cerebrovascular reactivity (± standard deviation) demonstrated in normals was 
36 ± 9%; this value was used to generate the statistical information given below. 
All comparisons were made using an unpaired, two-tailed Student's t-test. 
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All Stroke Patients 
Side of lesion n Mean (%) ± s.d. p-Value 
Ipsilateral 18 23.79 12.19 < 0.01 
Contralateral 18 30.56 12.22 0.08 
TIA Patients 
Side of lesion n Mean (%) ± s.d. p-Value 
Ipsilateral 8 37.05 10.43 0.78 
Contralateral 8 37.61 11.27 0.70 
Lacunar Strokes 
Side of lesion n Mean (%) ± s.d. p-Value 
Ipsilateral 4 31.10 14.87 0.56 
Contralateral 4 30.47 14.26 0.49 
Non-lacunar Strokes 
Side of lesion n Mean (%) ± s.d. p-Value 
Ipsilateral 14 21.70 11.05 < 0.01 
Contralateral 14 30.59 12.18 0.12 
Strokes with Superficial Lesions 
Side of lesion n Mean (%) ± s.d. p-Value 
Ipsilateral 9 20.21 11.90 < 0.01 
Contralateral 9 31.32 13.36 0.32 
Strokes with Deep Lesions 
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Side of lesion n Mean (%) ± s.d. p-Value 
Ipsilateral 8 29.67 10.53 0.13 
Contralateral 8 33.28 33.28 0.23 
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4. Discussion & Conclusion 
4.1 Discussion of the Findings 
These findings are consistent with the expectation that vasoreactivity is impaired 
in acute ischemic brain disease. What has been seen, however, is that this 
impairment is most pronounced in the setting of occlusive disease of 
thromboembolic nature, and in cases where there is permanent ischemic 
damage. Strokes that occurred secondary to small vessel disease (lacunar strokes) 
demonstrated less of a reactivity impairment, if any at all. Finally, vascular 
lesions that affected cortical regions demonstrated worse reactivity than those 
affecting sub-cortical regions. These differences are discussed below. 
4.1.1 Stroke and TIA 
It has been well documented in the literature that stroke patients demonstrate 
worse cerebrovascular reactivity that normal patients; TIA patients have not 
been extensively studied, however. The findings here show that, indeed, 
reactivity in stroke patients is significantly impaired, which is consistent with the 
principle that the resistance arterioles distal to the vessel in question—in this 
case the MCA—are maximally dilated and do not respond to an acetazolamide 
challenge. 
Patients with TIA, on the other hand, tend to show higher reactivity (i.e., less 
impaired) values than stroke patients. Many of these numbers are within the 
normal range, although many are slightly impaired. Thromboembolic and 
occlusive disease seem to be major factors in determining the degree to which 
reactivity is impaired; patients who experience transient ischemic attacks 
demonstrate a wide variety of responses, but the fact that their disease is not yet 
severe enough to produce a complete infarct may account for the vasomotor 
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reserve capacity to be left largely intact. Impaired reactivity seen in TIA patients 
may have some prognostic value, suggesting that further investigation into the 
patency of cerebral blood supply may prevent a stroke from occurring. 
4.1.2 Lacunar and Non-lacunar Infarcts 
Lacunar strokes result from small vessel disease, whereas non-lacunar strokes 
occur because of an embolus or pre-existing occlusive disease of the blood 
vessels. The artery affected in a lacunar stroke is, therefore, a small branch of a 
larger vessel, whereas in a non-lacunar stroke, occlusion of a larger artery creates 
a loss in blood flow for all the blood vessels fed by it. Since most of the resistance 
arterioles distal to the MCA would be unaffected in a lacunar stroke, they are 
probably not maximally dilated. That would explain why the patients with 
lacunar stroke exhibit reactivity similar to that of normal persons. 
4.1.3 Superficial, Deep and Combined Lesions 
The superficial lesions are caused by processes affecting the larger arteries, 
such as the MCA, so that an occlusion would result in its resistance arterioles 
being maximally dilated. Disease in a branch of the larger vessels (e.g. 
penetrating branches of the MCA) would not cause a large degree of 
compensatory vasodilation, so little change in CVR should be seen when 
looking at the MCA, as is seen in these findings. It is likely, however, that if the 
branch vessels were tested, a marked decrease in their reactivity would be seen. 
Finally, the combined lesions represent the largest extent of disease 
(involvement of cortical and non-cortical structures). Although statistical 
analysis was not possible with only one subject, the patient demonstrated 
extremely impaired reactivity. A lesion located in a very proximal segment of 
the MCA would account for such a large stroke and for such poor reactivity. 
■- 
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These findings suggest that increasingly poor reactivity may be associated with 
increasingly larger lesions. 
4.2 Some Limitations of this Study 
This study looked only at the reactivity of the middle cerebral artery (MCA). 
What was found that only ischemic strokes that affect the MCA territory 
demonstrate markedly impaired reactivity, and that strokes caused by vascular 
changes (lacunar strokes) or those affecting other territories may not show 
impaired reactivity in the MCA. Further studies that would be helpful in 
investigating the changes in stroke include looking at the reactivity of other 
vascular territories (e.g. vertebrobasilar system, posterior cerebral artery, anterior 
cerebral artery). Comparisons could be made after strokes affecting tissues 
supplied by these arteries, as well as strokes affecting the other territories. 
4.3 Implications of the Findings 
What implications do these findings have in understanding some of the 
pathophysiology of stroke, and how will this knowledge affect the management 
of acute stroke? The management of acute stroke focuses largely on the re¬ 
establishment of tissue perfusion through anticoagulation and thrombolysis as 
well as strict blood pressure control. With the loss of the brain's autoregulatory 
capacity following a stroke, keeping blood pressure slightly elevated and 
avoiding, in particular, the lowering of blood pressure may play a key role 
improving tissue perfusion. Close monitoring of the autoregulatory capacity can 
be achieved by following the cerebral vasoreactivity. As the brain's 
autoregulatory ability returns, and reactivity improves, less strict control on 
blood pressure may be possible. 
. 
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4.4 Future Directions and Questions 
A number of further investigations should be considered, in light of the 
findings presented here. 
1. A look at the reactivity in other vascular territories in order to better 
understand the characteristics of vasomotor reserve capacity. 
2. Successive reactivity studies conducted in a series of patients to 
determine any significant improvements in reactivity over time. 
3. An unpaired, prospective study comparing stroke patients who receive 
standard therapy and those in whom reactivity is used to guide blood 
pressure control. 
4.5 Concluding Remarks 
The intent of this research project was to compare vasomotor reactivity in a 
group of patients with cerebrovascular disease. While there is a great deal of 
knowledge that lies ahead, this study has added to scientific knowledge of one of 
the processes of brain function. Further understanding through investigation 
will have a positive impact on how patients with cerebrovascular disease are 
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5.1 Reactivity Test Result Sheet 
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5.1b. Sample of an abnormal study. 
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5.2 Patient Information Sheet 
REACTIVITY PATIENT INFORMATION 
INDENTIFICATION 
Last First Unit Number 
Date of Birth Age Attending MD 




Date of Admission 
Date of Discharge 
Est Age of Event 
Est Date of Event 
Date of Study 
Days since Event 
Initial Reactivity Results 
Left Right 
O Low O Low 
OHigh OHigh 
O Normal O Normal 
O Abnormal O Abnormal 
% CVR: % CVR: 
Follow-up done? 
Date of Follow Up 
Days since Event 
Follow-up Reactivity Results 
Left Right 
O Low O Low 
OHigh OHigh 
O Normal O Normal 
O Abnormal O Abnormal 




PMH: l.H/OCVA? Description: 
2. H/O HDz? Description: 
3. Other PMH: Description: 
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PSII: 1. Neurol Surg? 
2. Other Surg? 















Course of Treatment & Progress 
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5.3 Data Analysis Sheet 
PATIENT DATA ANALYSIS 










Initial Length of time (in Time range of greatest BL Peak %CVR 
Study minutes) to absolute velocity percent increase 
peak velocity: from baseline: 
LMCA- LMCA- LMCA- 
days after 
event RMCA- RMCA- RMCA- 
F/U Length of time (in Time range of greatest BL Peak %CVR 
Study minutes) to absolute velocity rate of increase 
peak velocity: from baseline: 
LMCA- LMCA- LMCA- 
days after 
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